No results for ‘’
Emmessar Biotech & Nutrition Ltd
NSE: BSE: 524768
₹26
(2.36%)
Mon, 25 May 2026, 10:05 am
Market Cap126.95M
PE Ratio31.95
Dividend0
Health Technology
Pharmaceuticals: Other
24.5KCompany History
1992
- The Company was incorporated as a Public Limited Company on 17th March 1992
- The certificate of commencement of business was obtained from Registrar of Companies, Maharashtra, Bombay on 20th March 1992
- The Company purchased land in the month of October 1992
1994
- The Company revalued the land admeasuring 16,126 Sq. meters in January 1994
- The value of the land was recorded at Rs.88,71,300 instead of Rs. 32,52,400
2005
- Emmessar Biotech entered into a strategic alliance with Twilight Mercantiles
2007
- Emmessar Biotech designated an E-mail ID for Investor Complaints
2008
- Emmessar Technologies Private Ltd became Emmessar Technologies Ltd
- RESQ was launched as an unfailing solution for treating all types of burns from heat and radiation
- Cute N Comely was launched as a premier topical application with protective and therapeutic properties for skin rejuvenation
2009
- Frejomus tablets were launched to help mitigate joint pains that restrict movement for the middle and old aged people.
2010
- Sepecer was launched as a reliable solution for neurological and physiological health for the middle ages and beyond.
2011
- Psoribalm was launched to meet the long standing demand for a harmless and reliable treatment for Psoriasis.
2016
- Over 30 newly developed products to meet a spectrum of healthcare needs were ready to be launched progressively from mid 2016 onwards.